[1]
Jarzynski, A. et al. 2017. TP53 promoter methylation in EBV and HPV associated oropharyngeal carcinoma – a pilot study. Current Issues in Pharmacy and Medical Sciences. 30, 3 (Dec. 2017), 119–122. DOI:https://doi.org/10.1515/cipms-2017-0021.